IRIS - Res&Arch Institutional Research Information System - Research & Archive

CAMAIONI, Emidio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.171
EU - Europa 2.641
AS - Asia 927
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 6
OC - Oceania 2
Totale 6.762
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.162
UA - Ucraina 661
IE - Irlanda 610
IT - Italia 419
SG - Singapore 311
SE - Svezia 249
HK - Hong Kong 247
DE - Germania 175
FI - Finlandia 158
CN - Cina 124
RU - Federazione Russa 122
VN - Vietnam 120
TR - Turchia 75
GB - Regno Unito 51
FR - Francia 47
PL - Polonia 31
CH - Svizzera 24
BE - Belgio 23
KR - Corea 22
CZ - Repubblica Ceca 17
NL - Olanda 15
GR - Grecia 12
RO - Romania 12
AT - Austria 11
EG - Egitto 7
IL - Israele 7
EU - Europa 6
LB - Libano 6
MX - Messico 5
UZ - Uzbekistan 5
CL - Cile 4
JP - Giappone 4
SV - El Salvador 4
ID - Indonesia 3
BR - Brasile 2
AU - Australia 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
IR - Iran 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SA - Arabia Saudita 1
Totale 6.762
Salva come PNG Salva come JPEG
Città #
Dublin 606
Chandler 555
Jacksonville 408
San Mateo 336
Hong Kong 245
Singapore 225
Boardman 214
Altamura 165
Medford 156
Princeton 154
Dong Ket 119
Lawrence 105
Perugia 105
Wilmington 103
Ann Arbor 97
Andover 86
Izmir 74
Redmond 58
Des Moines 55
Saint Petersburg 49
Beijing 48
Helsinki 23
Norwalk 23
Ashburn 22
Seoul 22
Brussels 21
San Paolo di Civitate 21
Los Angeles 19
Woodbridge 18
Dallas 14
Bucharest 11
Den Haag 11
Redwood City 11
Auburn Hills 10
Munich 10
New York 10
Rome 10
Santa Clara 9
Shanghai 9
Falls Church 8
Milan 8
Brno 7
Cairo 7
Chicago 7
San Diego 7
Lausanne 6
Mcallen 6
Ness Ziona 6
Olomouc 6
Renton 6
Simi Valley 6
Zhengzhou 6
Florence 5
Frankfurt Am Main 5
Kraków 5
Spoleto 5
Bologna 4
Centro 4
Fairfield 4
Gigante 4
Montefalco 4
Moscow 4
Tappahannock 4
Winston-Salem 4
Cassino 3
Collazzone 3
Detroit 3
Fremont 3
Houston 3
Malang 3
Nanjing 3
San Giustino 3
Strasbourg 3
Terni 3
Wuhan 3
Cambridge 2
Città di Castello 2
Esslingen am Neckar 2
Fuzhou 2
La Canada Flintridge 2
Las Vegas 2
Mestrino 2
Misano Adriatico 2
Nea Smyrni 2
Pittsford 2
Radomsko 2
Shenzhen 2
Tübingen 2
Warsaw 2
Abidjan 1
Amsterdam 1
Auckland 1
Barcelona 1
Bastia umbra 1
Birmingham 1
Boydton 1
Brescia 1
Budapest 1
Buffalo 1
Böblingen 1
Totale 4.447
Salva come PNG Salva come JPEG
Nome #
Computational studies in enantioselective liquid chromatography: Forty years of evolution in docking- and molecular dynamics-based simulations 119
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 100
Structure-activity relationships of bisphophonate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists 86
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 81
Towards New Neuroprotective Agents: Design and Synthesis of Thieno[2,3-c]-isoquinolinon-5-one as a Potent PARP-1 Inhibitor. 80
Spiro[2.2]pentane as a Dissymmetric Scaffold for Conformationally Constrained Analogues of Glutamic Acid: Focus on Racemic 1-Aminospiro[2.2]pentyl-1,4-dicarboxylic Acids 78
Novel PARP Inhibitors: Synthesis and Molecular Modeling Studies 75
Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage 75
Spiro[2.2]pentane as a dyssymetric scaffold for conformationally constrained analogues of glutamic acid: diastereodivergent synthesis of 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 75
Design and synthesis of 4H-thieno[2,3-c]isoquinolin-5-one derivatives as potent PARP-1 inhibitors, on route of new antiischemic agents 74
2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors 73
Metabotropic glutamate receptors: structure and new subtype-selective ligands 73
On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives. 72
Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis 68
PARP inhibitors: polypharmacology versus selective inhibition 68
Binding Mode of 6ECDCA, a Potent Bile Acid Agonist of the Farnesoid X Receptor (FXR) 67
Preparation and use of nucleotide bisphosphate as P2Y antagonists 65
Adenosine receptor agonists: Synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA 65
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 65
Integrated Fragment-Based Approaches on the Route to Novel IDO1 Modulators 65
Rat Brain Guanosine Binding Site:Biological Studies and Pseudo Receptor Construction 64
Targeting the FXR nuclear receptor through a virtual screening approach 63
1μs Molecular Dynamics Simulations to study the poisoning effect of the PARP-1 full length enzyme 63
N-Decyl-S-trityl-(R)-cysteine, a new chiral selector for "green" ligand-exchange chromatography applications 63
Effects of new arylazido compounds of pyridoxal phosphate on ecto-ATPase activity of guinea pig tissues 61
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles. 60
Dexpramipexole improves bioenergetics and outcome in experimental stroke 60
Adenosine Deaminase: Functional Implications and Different Classes of Inhibitors 59
Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ 59
Design, Molecular Modeling Studies, Synthesis and Preliminary Evaluation of Novel PARP-1 Inhibitors on the Road of Antiischemic Agents 58
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy. 57
Chiral separation of helical chromenes with chloromethyl phenylcarbamate polysaccharide-based stationary phases 57
New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures 57
2-Alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors. 56
Derived chromatographic indices as effective tools to study the self-aggregation process of bile acids 55
Chromatographic hydrophobicity index: a high-throughput tool to estimate the critical micellar concentration of bile acids 55
BF3·Et2O-Promoted Decomposition of Cyclic α-Diazo-β-Hydroxy Ketones: Novel Insights into Mechanistic Aspects 55
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. 55
Modeling of Poly(ADP-ribose)polymerase (PARP) Inhibitors. Docking of Ligands and QSAR 54
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists. 54
6a-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. 54
The Janus-faced nature of IDO1 in infectious diseases: Challenges and therapeutic opportunities 53
The relationship between s. Aureus and branched-chain amino acids content in composite cow milk 53
Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide. 52
6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity 52
Adenosine deaminase inhibitors: Structure-activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogues 52
8-Bromo-9-etiladenine come tools per l’ottenimento di antagonisti selettivi per il recettore adenosinico A2B 51
Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO). 50
Bile acids: property-activity relationship and molecular modelling studies 50
Chiral ligand-exchange separation and resolution of extremely rigid glutamate analogues: 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 50
Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites 50
Compendio teorico-pratico di analisi farmaceutica. Riconoscimento delle sostanze solide iscritte nelle vigenti farmacopee 50
Branched-chain amino acids as potential diagnostic and prognostic disease biomarkers 49
Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors 49
Highlights at the gate of tryptophan catabolism: a review on the mechanism of activation and regulation of indoleamine 2,3-dioxigenase (IDO), a novel target in cancer disease 48
Chiral ligand-exchange separation and resolution ofextremely rigid glutamate analogs: 1-aminospiro[2.2]pentyl-1,4-dicarboxylicacids. 48
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis 48
Synthesis and Biological Evaluation of 2-(3’-(1H-tetrazol-5-yl)bicyclo[1.1.1]pent-1-yl)glycine (S-TBPG), a novel mGlu1 Receptor 47
Fragment based drug design and diversity-oriented synthesis of carboxylic acid isosteres 47
Fast chromatographic determination of the bile salt critical micellar concentration 46
Stereoselective Synthesis and Preliminary Evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): Identification of (+)-3-MATIDA as a Novel mGluR1 Competitive Antagonist 45
Molecular determinats for metabotropic glutamate receptor activation and blockade. Molecular dynamics and electrostatic potential analysis studies 45
Studies on the interaction between PARP’s catalytic site and inhibitors. Design and synthesis of new class of inhibitor derivatives 45
Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors 45
Hydrophobic Amino Acid Content in Onions as Potential Fingerprints of Geographical Origin: The Case of Rossa da Inverno sel. Rojo Duro 45
Enantioselective HPLC analysis to assist the chemical exploration of chiral imidazolines 45
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 45
Estimating the hydrophobicity extent of molecular fragments using reversed‐phase liquid chromatography 44
Studies guanosine binding sites in rat brain: S.A.R. analysis and pharmacophore design 44
On the Way to Selective PARP-2 Inhibitors: Design, Synthesis and Preliminary Evaluation of a Series of Isoquinolinone Derivatives 44
Insights in the PARP1 poisoning effect 44
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase. 44
One Key and Multiple Locks: Substrate Binding in Structures of Tryptophan Dioxygenases and Hydroxylases 44
Dominant Factors Affecting the Chromatographic Behaviour of Bile Acids 43
Pharmacology of the highly selective A1 adenosine receptor agonist2-chloro-N6-cyclopentyladenosine. 43
Inhibitory Effects of 1-Deazaadenosine Analogues on HIV Replication and Adenosine Deaminase 43
Bile Acid Derivatives as Ligands of the Farnesoid X Receptor. Synthesis, Evaluation, and Structure Activity Relationship of a Series of Body and Side Chain Modified Analogs of Chenodeoxycholic Acid 43
Use of RP-HPLC on a Dynamically Coated Artificial Membrane to Predict Intestinal Absorption of Bile Acids 42
Synthesis, molecular modelling and preliminary evaluation of a series of new thioidantoine derivatives as inhibitors of indoleamine-2,3-dioxygenase (IDO) 42
Rat brain guanosine binding site. Biological studies and pseudo-Receptor construction 41
Synthesis, enantiomeric separation and preliminary evaluation of a series of new thioidantoine derivatives as inhibitors of indoleamine-2,3-dioxygenase (IDO), a novel target for cancer therapy 41
Design, Synthesis, Crystallographic Studies and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors. 41
Xaa-prolyl dipeptidyl aminopeptidase may play an important role in biofilm formation by Streptococcus mutans 41
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy 41
The relationships between somatic cells and isoleucine, leucine and tyrosine content in cow milk 41
HYDAMTIQ: A New, Potent PARP-1 Inhibitor with Neuroprotective Properties 40
Synthesis and Receptor Affinity of Polysubstituted Adenosines 40
Synthesis of New Nucleosides by coupling of chloropurines with 2- and 3-deoxy derivatives of N-methyl-D-ribofuranuronamide 39
New insights into the evaluation of the bile salt critical micellar concentration 39
Therapeutic Potential of a Novel Poly(ADP-ribose) Polymerase Inhibitor, Hydamtiq, in Human Pancreatic and Colon Cancers 39
Heterocycles as companions on route to drug discovery 38
Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin 38
Heterocycles as Companions on Route to Drug Discovery 38
Characterization of potent ligands at human recombinant adenosine receptors 38
Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure 37
High-throughput chromatographic determination of the bile acid critical micellar concentration 37
Synthesis and biological activity of 3'-deoxy derivative of adenosine (5'-N-methylcarboxamide) (MECA) 37
Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent 36
Combined strategies toward the design and synthesis, of novel inhibitors of indoleamine-2,3-dioxygenase (IDO) 36
RP-18-BASE-DEACTIVATED, una nuova fase stazionaria per l’analisi cromatografica degli acidi biliari 36
Totale 5.337
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.439
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020458 0 0 0 0 107 7 107 7 109 70 19 32
2020/20211.330 3 107 31 100 405 69 121 29 169 32 119 145
2021/20221.214 33 212 11 54 37 11 13 405 43 51 138 206
2022/20232.058 165 391 30 121 178 215 3 83 760 7 76 29
2023/2024851 47 104 44 12 7 15 182 29 88 28 132 163
2024/2025376 22 202 73 62 17 0 0 0 0 0 0 0
Totale 7.142